Clinical Trials Logo

KRAS Gene Mutation clinical trials

View clinical trials related to KRAS Gene Mutation.

Filter by:
  • No longer available  
  • Page 1

NCT ID: NCT04446793 No longer available - Clinical trials for Metastatic Colorectal Cancer

Expanded Access of Onvansertib With FOLFIRI and Bevacizumab for the Second-Line Treatment of Participants With KRAS-Mutated Metastatic Colorectal Cancer

Start date: n/a
Phase:
Study type: Expanded Access

This is an expanded access program for eligible participants designed to provide access to onvansertib in combination with FOLFIRI and bevacizumab.